Neuphoria Therapeutics Inc(NEUP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NEUP Neuphoria Therapeutics Inc

交易中 07-16 10:13:29 EDT

7.41

-0.15

-1.98%

最高7.59	最低7.40	成交量1.82万
今开7.59	昨收7.56	日振幅2.50%
总市值1,393万	流通市值627.03万	总股本188.00万
成交额13.54万	换手率2.15%	流通股本84.62万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NEUP","market":"US","secType":"STK","nameCN":"Neuphoria Therapeutics Inc","latestPrice":7.41,"timestamp":1752675182187,"preClose":7.56,"halted":0,"volume":18166,"delay":0,"floatShares":846200,"shares":1879962,"eps":0.001699,"marketStatus":"交易中","change":-0.15,"latestTime":"07-16 10:13:29 EDT","open":7.5893,"high":7.5893,"low":7.4,"amount":135352.7987092,"amplitude":0.02504,"askPrice":7.51,"askSize":100,"bidPrice":7.3,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":0.001699,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1752696000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":7.56,"preHourTrading":{"tag":"盘前","latestPrice":7.56,"preClose":7.56,"latestTime":"08:00 EDT","volume":25,"amount":189,"timestamp":1752667209902},"volumeRatio":4.378408},"requestUrl":"/m/hq/s/NEUP","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.neuphoriatx.com","stockEarnings":[{"period":"1week","weight":0.05},{"period":"1month","weight":0.1092},{"period":"3month","weight":0.4795},{"period":"6month","weight":1.5116},{"period":"1year","weight":1.4891},{"period":"ytd","weight":1.2041}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.0421},{"period":"3month","weight":0.1835},{"period":"6month","weight":0.0516},{"period":"1year","weight":0.1079},{"period":"ytd","weight":0.0615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neuphoria Therapeutics Inc.（原名Bionomics Limited）于1996年根据澳大利亚法律注册成立，并于2024年12月24日迁移至特拉华州并成为国内公司。该公司是一家临床阶段的生物制药公司，开发新型变构离子通道调节剂，旨在改变患有严重中枢神经系统疾病的患者的生活，这些患者的医疗需求未得到满足。该公司正在开发口服活性小分子负变构调节剂和α7受体正变构调节剂，分别用于治疗焦虑和压力相关疾病和认知功能障碍。该公司正在推进Ead候选产品BNC210，这是一种口服的、专有的、选择性的α7受体NAM，用于创伤后应激障碍的慢性治疗和社交焦虑障碍的急性治疗。","exchange":"NASDAQ","name":"Neuphoria Therapeutics Inc","nameEN":"Neuphoria Therapeutics Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Neuphoria Therapeutics Inc(NEUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Neuphoria Therapeutics Inc(NEUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Neuphoria Therapeutics Inc,NEUP,Neuphoria Therapeutics Inc股票,Neuphoria Therapeutics Inc股票老虎,Neuphoria Therapeutics Inc股票老虎国际,Neuphoria Therapeutics Inc行情,Neuphoria Therapeutics Inc股票行情,Neuphoria Therapeutics Inc股价,Neuphoria Therapeutics Inc股市,Neuphoria Therapeutics Inc股票价格,Neuphoria Therapeutics Inc股票交易,Neuphoria Therapeutics Inc股票购买,Neuphoria Therapeutics Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Neuphoria Therapeutics Inc(NEUP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Neuphoria Therapeutics Inc(NEUP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}